Meerit Y. Said

Meerit Y. Said

Auto-generated profile, based on publicly available information

Meerit Y. Said

Institute for Protein Design, University of Washington, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2024 in Science
Verified
Journal Article
Open access
LALinna An
Linna An
MSMeerit Said
Meerit Said
LTLong Tran
Long Tran
SMSagardip Majumder
Sagardip Majumder
IGInna Goreshnik
Inna Goreshnik
DBDavid Baker
David Baker
We describe an approach for designing high-affinity small molecule–binding proteins poised for downstream sensing. We use deep learning–generated pseudocycles with repeating structural units surrounding central binding pockets with widely varying shapes that depend on the geometry and number of the repeat units. We dock small molecules of interest into the most shape complementary of these pseudocycles, design the interaction surfaces for high binding affinity, and experimentally screen to identify designs with the highest affinity. We obtain binders to four diverse molecules, including the polar and flexible methotrexate and thyroxine. Taking advantage of the modular repeat structure and central binding pockets, we construct chemically induced dimerization systems and low-noise nanopore sensors by splitting designs into domains that reassemble upon ligand addition.

26 April 2024 in Science
Verified
Journal Article
Closed access
PSPatrick J. Salveson
Patrick J. Salveson
AMAdam P. Moyer
Adam P. Moyer
MSMeerit Y. Said
Meerit Y. Said
GGGizem Gӧkçe
Gizem Gӧkçe
XLXinting Li
Xinting Li
DBDavid Baker
David Baker
Small macrocycles with four or fewer amino acids are among the most potent natural products known, but there is currently no way to systematically generate such compounds. We describe a computational method for identifying ordered macrocycles composed of alpha, beta, gamma, and 17 other amino acid backbone chemistries, which we used to predict 14.9 million closed cycles composed of >42,000 monomer combinations. We chemically synthesized 18 macrocycles predicted to adopt single low-energy states and determined their x-ray or nuclear magnetic resonance structures; 15 of these were very close to the design models. We illustrate the therapeutic potential of these macrocycle designs by developing selective inhibitors of three protein targets of current interest. By opening up a vast space of readily synthesizable drug-like macrocycles, our results should considerably enhance structure-based drug design.

10 January 2022 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
ABAnika L. Burrell
Anika L. Burrell
CNChuankai Nie
Chuankai Nie
MSMeerit Said
Meerit Said
JSJacqueline C. Simonet
Jacqueline C. Simonet
DFDavid Fernández-Justel
David Fernández-Justel
JKJustin M. Kollman
Justin M. Kollman

25 October 2022 in Chemistry of Materials
Verified
Journal Article
Open access
MSMeerit Y. Said
Meerit Y. Said
CKChristine S. Kang
Christine S. Kang
SWShunzhi Wang
Shunzhi Wang
WSWilliam Sheffler
William Sheffler
PSPatrick J. Salveson
Patrick J. Salveson
DBDavid Baker
David Baker
Despite remarkable advances in the assembly of highly structured coordination polymers and metal-organic frameworks, the rational design of such materials using more conformationally flexible organic ligands such as peptides remains challenging. In an effort to make the design of such materials fully programmable, we first developed a computational design method for generating metal-mediated 3D frameworks using rigid and symmetric peptide macrocycles with metal-coordinating sidechains. We solved the structures of six crystalline networks involving conformationally constrained 6 to 12 residue cyclic peptides with C2, C3, and S2 internal symmetry and three different types of metals (Zn2+, Co2+, or Cu2+) by single-crystal X-ray diffraction, which reveals how the peptide sequences, backbone symmetries, and metal coordination preferences drive the assembly of the resulting structures. In contrast to smaller ligands, these peptides associate through peptide-peptide interactions without full coordination of the metals, contrary to one of the assumptions underlying our computational design method. The cyclic peptides are the largest peptidic ligands reported to form crystalline coordination polymers with transition metals to date, and while more work is required to develop methods for fully programming their crystal structures, the combination of high chemical diversity with synthetic accessibility makes them attractive building blocks for engineering a broader set of new crystalline materials for use in applications such as sensing, asymmetric catalysis, and chiral separation.

18 May 2026 in Nature Communications
Verified
Journal Article
Open access
SHStephanie Hanna
Stephanie Hanna
PSPatrick J. Salveson
Patrick J. Salveson
BWBasile Wicky
Basile Wicky
MKMadison A. Kennedy
Madison A. Kennedy
DHDerrick R. Hicks
Derrick R. Hicks
DBDavid Baker
David Baker
Investigating and manipulating cellular events requires precise control of protein function. To enable control over cellular processes, we set out to design a chemically induced dimerization (CID) system consisting of a de novo-designed ligand and protein pair. Here, we describe the design of a C2 symmetric membrane-permeable macrocyclic peptide and a cognate protein homodimer which binds the macrocycle through a large interface with both chains. The designed homodimer binds the macrocycle with a K D of 36 nM, and the x-ray crystal structure of the protein homodimer-macrocycle complex is very close to the computational design model, with the C2 axis of the macrocycle aligned with the homodimer C2 axis. Transcriptional and split luciferase assays in mammalian cells demonstrate conditional control over both a reporter gene expression and luciferase reconstitution.